Loading…

Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion

Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated. Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90),...

Full description

Saved in:
Bibliographic Details
Published in:American journal of health-system pharmacy 2010-06, Vol.67 (11), p.914-918
Main Authors: Crill, Catherine M, Hak, Emily B, Robinson, Lawrence A, Helms, Richard A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3
cites cdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3
container_end_page 918
container_issue 11
container_start_page 914
container_title American journal of health-system pharmacy
container_volume 67
creator Crill, Catherine M
Hak, Emily B
Robinson, Lawrence A
Helms, Richard A
description Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated. Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur. None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13). Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.
doi_str_mv 10.2146/ajhp090199
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_733548228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A231714685</galeid><sourcerecordid>A231714685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</originalsourceid><addsrcrecordid>eNptkV1r1zAUxoM43Jze-AGkICgMOpM0fbscY3ODgTd6HU6bkzWjbWqSrnjrJ9_506kIkosccn7Pw5NzGHsn-LkUqvoMD8PCWy7a9gU7EWVR5rLl_CXVvG5zyRt5zF7H-MC5kA2vXrFjyVWjpChP2K-rRxhXSM7PmbfZ5PrgOwdj1vs5weTmvQUx-t5BQpNtLg2ZcdZiwDllS8AFwk5NmAZvYmZ9yGb0pCUjN6cAjzj7lRqQMpzWMR5oN9v1ULxhRxbGiG-f71P2_frq2-VNfvf1y-3lxV3eF41KOZpOdQgged9xUVaqQGvAYG1r6Ku2K1VfVlgZLgpRq9q0UFpeoeyo36i2K07Zp913Cf7HijHpycUexxEo6xp1XRSlaqRsiPywk_cwoqacnr7QH2h9Icmdht6URJ3_h6JjkMboZ7SO3v8RnO0CmnGMAa1egpsg_NSC68Mm9d9NEvz-Oe3aTWj-oL9XR8DHHRjc_bC5gDpOMI6ES71tW1VrIXQrVPEETqyqAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733548228</pqid></control><display><type>article</type><title>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</title><source>Oxford Journals Online</source><creator>Crill, Catherine M ; Hak, Emily B ; Robinson, Lawrence A ; Helms, Richard A</creator><creatorcontrib>Crill, Catherine M ; Hak, Emily B ; Robinson, Lawrence A ; Helms, Richard A</creatorcontrib><description>Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated. Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur. None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13). Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.</description><identifier>ISSN: 1079-2082</identifier><identifier>EISSN: 1535-2900</identifier><identifier>DOI: 10.2146/ajhp090199</identifier><identifier>PMID: 20484215</identifier><language>eng</language><publisher>England: American Society of Health-System Pharmacists</publisher><subject>Bacteria - isolation &amp; purification ; Contamination ; Drug Compounding - methods ; Drug Compounding - standards ; Drug Contamination ; Drug Packaging ; Drug Storage ; Fat Emulsions, Intravenous - standards ; Humans ; Hypodermic needles ; Hypodermic syringes ; Infant, Newborn ; Infusions, Intravenous ; Intravenous therapy ; Microbial contamination ; Pharmacy Service, Hospital - methods ; Prevention ; Safety and security measures ; Syringes ; Syringes - microbiology ; Time Factors</subject><ispartof>American journal of health-system pharmacy, 2010-06, Vol.67 (11), p.914-918</ispartof><rights>COPYRIGHT 2010 Oxford University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</citedby><cites>FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20484215$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crill, Catherine M</creatorcontrib><creatorcontrib>Hak, Emily B</creatorcontrib><creatorcontrib>Robinson, Lawrence A</creatorcontrib><creatorcontrib>Helms, Richard A</creatorcontrib><title>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</title><title>American journal of health-system pharmacy</title><addtitle>Am J Health Syst Pharm</addtitle><description>Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated. Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur. None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13). Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.</description><subject>Bacteria - isolation &amp; purification</subject><subject>Contamination</subject><subject>Drug Compounding - methods</subject><subject>Drug Compounding - standards</subject><subject>Drug Contamination</subject><subject>Drug Packaging</subject><subject>Drug Storage</subject><subject>Fat Emulsions, Intravenous - standards</subject><subject>Humans</subject><subject>Hypodermic needles</subject><subject>Hypodermic syringes</subject><subject>Infant, Newborn</subject><subject>Infusions, Intravenous</subject><subject>Intravenous therapy</subject><subject>Microbial contamination</subject><subject>Pharmacy Service, Hospital - methods</subject><subject>Prevention</subject><subject>Safety and security measures</subject><subject>Syringes</subject><subject>Syringes - microbiology</subject><subject>Time Factors</subject><issn>1079-2082</issn><issn>1535-2900</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNptkV1r1zAUxoM43Jze-AGkICgMOpM0fbscY3ODgTd6HU6bkzWjbWqSrnjrJ9_506kIkosccn7Pw5NzGHsn-LkUqvoMD8PCWy7a9gU7EWVR5rLl_CXVvG5zyRt5zF7H-MC5kA2vXrFjyVWjpChP2K-rRxhXSM7PmbfZ5PrgOwdj1vs5weTmvQUx-t5BQpNtLg2ZcdZiwDllS8AFwk5NmAZvYmZ9yGb0pCUjN6cAjzj7lRqQMpzWMR5oN9v1ULxhRxbGiG-f71P2_frq2-VNfvf1y-3lxV3eF41KOZpOdQgged9xUVaqQGvAYG1r6Ku2K1VfVlgZLgpRq9q0UFpeoeyo36i2K07Zp913Cf7HijHpycUexxEo6xp1XRSlaqRsiPywk_cwoqacnr7QH2h9Icmdht6URJ3_h6JjkMboZ7SO3v8RnO0CmnGMAa1egpsg_NSC68Mm9d9NEvz-Oe3aTWj-oL9XR8DHHRjc_bC5gDpOMI6ES71tW1VrIXQrVPEETqyqAg</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Crill, Catherine M</creator><creator>Hak, Emily B</creator><creator>Robinson, Lawrence A</creator><creator>Helms, Richard A</creator><general>American Society of Health-System Pharmacists</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100601</creationdate><title>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</title><author>Crill, Catherine M ; Hak, Emily B ; Robinson, Lawrence A ; Helms, Richard A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Bacteria - isolation &amp; purification</topic><topic>Contamination</topic><topic>Drug Compounding - methods</topic><topic>Drug Compounding - standards</topic><topic>Drug Contamination</topic><topic>Drug Packaging</topic><topic>Drug Storage</topic><topic>Fat Emulsions, Intravenous - standards</topic><topic>Humans</topic><topic>Hypodermic needles</topic><topic>Hypodermic syringes</topic><topic>Infant, Newborn</topic><topic>Infusions, Intravenous</topic><topic>Intravenous therapy</topic><topic>Microbial contamination</topic><topic>Pharmacy Service, Hospital - methods</topic><topic>Prevention</topic><topic>Safety and security measures</topic><topic>Syringes</topic><topic>Syringes - microbiology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crill, Catherine M</creatorcontrib><creatorcontrib>Hak, Emily B</creatorcontrib><creatorcontrib>Robinson, Lawrence A</creatorcontrib><creatorcontrib>Helms, Richard A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of health-system pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crill, Catherine M</au><au>Hak, Emily B</au><au>Robinson, Lawrence A</au><au>Helms, Richard A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion</atitle><jtitle>American journal of health-system pharmacy</jtitle><addtitle>Am J Health Syst Pharm</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>67</volume><issue>11</issue><spage>914</spage><epage>918</epage><pages>914-918</pages><issn>1079-2082</issn><eissn>1535-2900</eissn><abstract>Microbial contamination associated with different methods of neonatal intravenous fat emulsion (IVFE) preparation and delivery was evaluated. Sterility testing was performed on IVFE dispensed via three different methods: (1) in the original container (n = 60), (2) repackaged into a syringe (n = 90), and (3) drawdown of the original container (n = 60). At the end of each infusion (24 hours for methods 1 and 3, 12 hours for method 2), a sample of the IVFE was withdrawn from the container using a sterile syringe in an International Organization for Standardization class 5 hood and sent to the hospital microbiology laboratory, where the samples were introduced into blood culture bottles and incubated for five days. Each sample was then subcultured on a blood agar plate with olive oil and left for an additional two days in a carbon dioxide incubator to assess for Malassezia furfur. None of the samples from the original containers showed bacterial or fungal growth. Three of the samples from syringes had bacterial growth (two samples contained coagulase-negative staphylococcus and one contained both Klebsiella oxytoca and Citrobacter freundii), yielding a contamination rate of 3.3%. The number of contaminated samples did not significantly differ among the three preparation methods (p = 0.13). Repackaging IVFE into sterile syringes resulted in bacterial contamination and should be avoided in clinical practice. IVFE samples obtained using the drawdown procedure under sterile conditions for infusion over 24 hours revealed no microbial contamination.</abstract><cop>England</cop><pub>American Society of Health-System Pharmacists</pub><pmid>20484215</pmid><doi>10.2146/ajhp090199</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1079-2082
ispartof American journal of health-system pharmacy, 2010-06, Vol.67 (11), p.914-918
issn 1079-2082
1535-2900
language eng
recordid cdi_proquest_miscellaneous_733548228
source Oxford Journals Online
subjects Bacteria - isolation & purification
Contamination
Drug Compounding - methods
Drug Compounding - standards
Drug Contamination
Drug Packaging
Drug Storage
Fat Emulsions, Intravenous - standards
Humans
Hypodermic needles
Hypodermic syringes
Infant, Newborn
Infusions, Intravenous
Intravenous therapy
Microbial contamination
Pharmacy Service, Hospital - methods
Prevention
Safety and security measures
Syringes
Syringes - microbiology
Time Factors
title Evaluation of microbial contamination associated with different preparation methods for neonatal intravenous fat emulsion infusion
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A05%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20microbial%20contamination%20associated%20with%20different%20preparation%20methods%20for%20neonatal%20intravenous%20fat%20emulsion%20infusion&rft.jtitle=American%20journal%20of%20health-system%20pharmacy&rft.au=Crill,%20Catherine%20M&rft.date=2010-06-01&rft.volume=67&rft.issue=11&rft.spage=914&rft.epage=918&rft.pages=914-918&rft.issn=1079-2082&rft.eissn=1535-2900&rft_id=info:doi/10.2146/ajhp090199&rft_dat=%3Cgale_proqu%3EA231714685%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-edb4beaa20cb015643efdade7f7ac69b54c56e6d0131747d9a5f06e2bf7a849b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733548228&rft_id=info:pmid/20484215&rft_galeid=A231714685&rfr_iscdi=true